UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

Lancet

Volumn 350, Issue 9087, 1997, Pages 1288-1293

  Turner, Robert ^a   Stratton, Irene ^a   Horton, Virginia ^a   Manley, Sue ^a   Zimmet, Paul ^b   Mackay, Ian R ^c   Shattock, Marion ^d   Bottazzo, Gian Franco ^d   Holman, Runy ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CYTOPLASM; FEMALE; FOLLOW UP; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031560175     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)03062-6     Document Type: Article

References (30)

1. Bottazzo GF. On the honey disease: a dialogue with Socrates. Diabetes 1993; 42: 778-80.
2. Krolewski AS, Warram JH, Rand LI, Kahn CK. Epidemiological approach to the etiology of Type 1 diabetes mellitus and its complications. N Engl J Med 1987; 317: 1390-97.
3. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; ii: 1279-83.
4. Baekkeskov V, Aanstoot HJ, Christgau S, et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA synthesising enzyme glutamic acid decarboxylase. Nature 1990; 347: 152-56.
5. Bonifacio E, Genovese S, Braghi S, et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816-22.
6. Verge CF, Howard NJ, Rowley MJ, et al. Antiglutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologica 1994; 37: 113-20.
7. Riley WJ, Maclaren NK, Krischer J, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990; 323: 1167-72.
8. Irvine WJ, McCallum CJ, Gray RS, Duncan LT. Clinical and pathogenic significance of pancreatic-islet cell antibodies in diabetics treated with oral hypoglycaemic agents. Lancet 1977; 1: 1025-27.
9. Gleichman H, Zorcher B, Greulich B, et al. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 1984; 27: 90-92.
10. Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type 1 diabetes in patients aged 35-37 years at diagnosis. Diabetes 1986; 35: 237-41.
11. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of diabetes. Diabetes 1993; 42: 359-62.
12. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K. Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type 1 diabetes. Diabetes 1987; 36: 510-17.
13. Anon. Insulin-dependent? Lancet 1985; ii: 809-10.
14. Zimmet PZ, Tuomi T, Mackay IR, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994; 11: 299-303.
15. Gottsätter A, Landin-Olsson M, Lernmark A, Fernlund P, Sundkvist G, Hogopian WA. Glutamic decarboxylase antibody levels predict rate of B-cell decline in adult-onset diabetes. Diabetes Res Clin Pract 1995; 27: 133-40.
16. Willis JA, Scott RS, Brown LJ, et al. Islet-cell antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus. Diabetes Res Clin Pract 1996; 33: 89-97.
17. Niskanen LK, Tuomi T, Karjalainan J, Groop LC, Uusitupa MIJ. GAD antibodies in NIDDM. Diabetes Care 1995; 18: 1557-65.
18. UKPDS Group. UK Prospective Diabetes Study VIII: study design, progress and performance. Diabetologia 1991; 34: 877-90.
19. Bonifacio E, Bingley PJ, Shattock M, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147-49.
20. Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992; 41: 548-51.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
22. Chen Q, Rowley MJ, Byrne GC, et al. Antibodies to glutamic acid decarboxylase in Australian children and their first-degree relatives. Pediatr Res 1993; 34: 785-90.
23. Bingley PJ, Christie MR, Bonifacio E, et al. Combined analysis of auto antibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-10.
24. Seissler J, Morgenthaler NG, Achenback P, et al. Combined screening for auto antibodies to iA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 1996; 39: 1351-56.
25. UKPDS Group. UK Prospective Diabetes Study 24: relative efficacy of sulfonylurea, insulin and metformin therapy in newly diagnosed non-insulin dependent diabetes with primary diet failure followed for six years (in press).
26. Nabarro JD. Diabetes in the United Kingdom: a personal series. Diabet Med 1991; 8: 59-68.
27. Groop L, Miettinen A, Groop P-H, Meri S, Koskimies S, Bottazzo GF. Organ-specific autoimmunity and HLA-DR antigens as markers for B-cell destruction in patients with Type 2 diabetes. Diabetes 1988; 37: 99-103.
28. Kobayashi T, Tamemoto K, Nakinishi K, et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993; 16: 780-88.
29. Clark A, Wells CA, Buley ID, et al. Islet amyloid, increased A-cells, reduced b-cells and exocrine fibrosis: quantitative changes in the pancreas in Type 2 diabetes. Diabetes Res 1988; 9: 151-60.
30. 65 antibodies in insulin-dependent diabetes (IDDM), malnutrition-related diabetes (MRDM) and non-insulin dependent diabetes (NIDDM) patients from eastern India. Diabetologia 1996; 39: S301.